What's the highlight of the G20 summit at the Oncology Conference.

(Health Times reporter Jing Chao Huang Lanjun) for the first time in 30 years to China, the world's top tumor big curry gathered in Chengdu to talk about cancer metastasis. On September 15th-20th, the 16th World Conference on Tumor Metastiasanda and the 12th National Conference on Tumor Metastasis, known as the G20 Summit of The Oncology, were held in Chengdu, Sichuan Province. This is the first time that the International Association for Tumor Metastasis has moved to China, and the first time it has been held in An Asian country, attended by nearly a thousand experts and scholars, including Nobel Laureates, Members of the United States, European And National Fellows, and the Editorial Board of Top Academic Journals such as Nature.the 16th World Conference on Tumor Metastatable and the opening of the 12th National Conference on Tumor Metastalocation (Xinhua)
8 years of efforts to promote MRS 2016 China
International Society for Tumor Metastasis was founded in 1962, is the world's only international cancer academic organization, is also the global tumor The largest, highest-profile and far-reaching academic event in metastatic research, held every two years since 1984, aims to provide scientists around the world who study the direction of tumor metastasis a platform to communicate with each other and discuss the latest developments in the world to jointly tackle the world's problems of poor tumor prognosis and high mortality due to tumor metastasis.
, Chairman of the Chinese Anticancer Association's Cancer Transfer Professional Committee, Director of the Center for Lung Cancer at Huaxi Hospital of Sichuan University, and Director of the Sichuan Cancer Research Institute,
submitted an application to hold the academic conference in China at the 2008 MRS Annual Meeting in Vancouver, Canada. At an academic conference in Sydney, Australia, in 2012, the Chinese Cancer Transfer Professional Committee sponsored and supported an issue for the first time. Finally, at the Heidelberg Transfer Conference in 2014, Chengdu, China, won the bid city to become the host city for the 2016 conference.
5 bright spots, gathered the frontier field of tumor metastasis
as China's largest and highest specifications of the International Conference on Tumor Metastasis, basic clinical, translational medicine, etc. have been multi-faceted exchanges and interaction.
, Professor Joan Massague, director of the Memorial Sloan-Kettering Cancer Center in the United States, was the keynote speaker of the field of metastatic research, and more than 40 top international experts and scholars described the latest advances in tumor metastasis-related foundations, clinical and translational medicine research, the corresponding increase in the proportion of Chinese research and reports, and satellite conferences for young researchers, with the editorial boards of leading international academic journals such as Nature and the luncheon for oncology patients.conference is now

Zhou Qinghua told reporters that the World Conference on Tumor Metastasis is actively promoting the Coming to China with the aim of strengthening domestic and international integration. It has greatly enhanced China's academic status in the field of tumor metastasis research, further highlighting the development achievements of the field of tumor metastasis in China. At the same time, the China Anti-Cancer Association Cancer Transfer Professional Committee will be the sister society with the International Cancer Transfer Research Society, the two sides to carry out mutual recognition of members, establish a good international cooperation model, not only facilitate the exchange and learning of young scholars and foreign experts, but also significantly enhance China's influence and voice in the field of Asia-Pacific and international tumor metastasis. At the same time, we can build a complete talent system by enriching the disciplines and promote the development of other disciplines related to cancer.The
Conference was chaired by the President of the International Society for Oncology Metastasis, Professor Shriman of the University of Heidelberg, The President-designate of the International Society for Oncology Research, Professor Zhou Qinghua, President of Princeton University, and The President of the Chinese Society for Oncology Metastasis, and invited two Nobel Laureates, including Professor Breay of the United Kingdom, Professor Boyt of the United States, and more than 20 american, European and two academicians as academic scholars. At the same time, "nature", "cells", "science" and other 10 global medical journal editor-in-chief was invited to participate.
.